Relapsed and refractory peripheral T-cell lymphoma
Showing 9976 - 10000 of >10,000
Alzheimer, MDD Trial in New York, Orangeburg (Escitalopram Oxalate, Placebo)
Recruiting
- Alzheimer Disease
- Major Depressive Disorder
- Escitalopram Oxalate
- Placebo
-
New York, New York
- +1 more
Dec 29, 2022
Hepatocellular Carcinoma Trial in Brussels (Radioembolization using Holmium-166)
Active, not recruiting
- Hepatocellular Carcinoma
- Radioembolization using Holmium-166
-
Brussels, Anderlecht, BelgiumHôpital Universitaire Erasme, ULB
Dec 7, 2022
Hematologic Tumors Trial in France (Allogeneic (Allo) hematopoietic stem cell transplantation)
Completed
- Hematologic Neoplasms
- Allogeneic (Allo) hematopoietic stem cell transplantation
-
Amiens, France
- +13 more
Jan 27, 2023
Low Back Pain Trial in Hong Kong (Peripheral stimulation of acupuncture points (PSAP), Peripheral nerve field stimulation
Active, not recruiting
- Low Back Pain
- Peripheral stimulation of acupuncture points (PSAP)
- Peripheral nerve field stimulation (PNFS)
-
Hong Kong, ChinaDeaprtment of Anaesthesiology, The University of Hong Kong
May 17, 2022
Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer Trial in United States (PF-07104091 monotherapy dose escalation,
Recruiting
- Small Cell Lung Cancer
- +4 more
- PF-07104091 monotherapy dose escalation
- +8 more
-
Clive, Iowa
- +22 more
Apr 26, 2022
Hematological Patients, Bleeding, Platelet Refractoriness Trial in Saint-Étienne (Fibrinogen Concentrate Human)
Not yet recruiting
- Hematological Patients
- +2 more
- Fibrinogen Concentrate Human
-
Saint-Étienne, FranceCHU de Saint-Etienne
Feb 7, 2022
Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)
Completed
- Prostate Cancer
- +6 more
- MGA271
-
Los Angeles, California
- +11 more
Feb 4, 2022
Patients With Systemic Lupus Erythematosus
Recruiting
- Lupus Nephritis
-
Bruxelles, BelgiumCliniques universitaires Saint-Luc
Jun 29, 2022
Melanoma, Renal Cell Carcinoma Trial in Hull (Zirconium 89Zr crefmirlimab berdoxam)
Recruiting
- Melanoma
- Renal Cell Carcinoma
- Zirconium 89Zr crefmirlimab berdoxam
-
Hull, United KingdomCastle Hill Hospital
Feb 15, 2023
Non Small Cell Lung Cancer Trial in Worldwide (IPH5201 + durvalumab + standard chemo)
Recruiting
- Non Small Cell Lung Cancer
- IPH5201 + durvalumab + standard chemotherapy
-
Tampa, Florida
- +23 more
Feb 23, 2023
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +13 more
- Anastrozole
- +9 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 6, 2023
Food and Cooking Skills, and Eating Behaviors in People With
Completed
- Obesity
- Overweight
- Food and cooking skills
-
Balıkesir, TurkeyYeni mh. Bandirma Onyedi Eylul University Faculty of Health Scie
Oct 12, 2022
Brain Metastases, Renal Cell Carcinoma Trial in Houston (Nivolumab, Ipilimumab, Cabozantinib)
Not yet recruiting
- Brain Metastases
- Renal Cell Carcinoma
- Nivolumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial in United States (drug,
Recruiting
- Lung Non-Small Cell Carcinoma
- +2 more
- Atezolizumab
- +4 more
-
Anchorage, Alaska
- +308 more
Feb 2, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +5 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jul 14, 2022
Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial (Poziotinib
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +3 more
- Poziotinib Hydrochloride
- 1429757-68-5, HM781-36B, NOV-1201 Hydrochloride, NOV120101 Hydrochloride, Poziotinib HCl, POZIOTINIB HYDROCHLORIDE
- (no location specified)
Jul 18, 2022
Parkinson Disease Trial in Minneapolis (ursodeoxycholic acid)
Completed
- Parkinson Disease
- ursodeoxycholic acid
-
Minneapolis, MinnesotaCenter for Magnetic Resonance Research
Mar 7, 2022
Corneal Persistent Epithelial Defect Trial in Edgewood (NEXAGON High Dose Concentration, NEXAGON Low Dose Concentration, NEXAGON
Recruiting
- Corneal Persistent Epithelial Defect
- Nexagon® (lufepirsen) High Dose Concentration
- +3 more
-
Los Angeles, California
- +4 more
Aug 25, 2022
Results of Specific Gene Testing and Efficacy of Targeted
Completed
- Non Small Cell Lung Cancer
-
Changsha, Hunan, ChinaHunan Cancer hospital
Mar 27, 2023
Upper Extremity Exercise Capacity, Muscle Oxygenation, Balance
Completed
- Cystic Fibrosis
-
Ankara, Turkey
- +1 more
Mar 21, 2022
Ultrasound Maturation Grade in physiologIcal Term Pregnancies
Not yet recruiting
- Placenta Diseases
- (no location specified)
Mar 3, 2023